Loading...
Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
Deeper understanding of the pathobiology of non-small-cell lung cancer (NSCLC) has led to the development of small molecules that target genetic mutations known to play critical roles in the progression to metastatic disease. The discovery of epidermal growth factor receptor (EGFR) mutations in 15%–...
Na minha lista:
| Udgivet i: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217512/ https://ncbi.nlm.nih.gov/pubmed/28210145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S50671 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|